Chemokines such as CCL2 and CCL5 attract immune cells to the tumor site, facilitating a robust immune attack, critical for combating tumor heterogeneity and adaptive resistance mechanisms [13, 127, 128]. The gene discussed is CCL5; the disease is neoplasm.